Selected new reviews and commentaries, 9 October 2008

9 October 2008

Genomic medicine in developing countries
Special supplement to October issue of Nature Reviews Genetics

Explaining human uniqueness: genome interactions with environment, behaviour and culture.

Varki A, Geschwind DH, Eichler EE. Nat Rev Genet. 2008 Oct;9(10):749-63. Review.

The genetics of mammalian circadian order and disorder: implications for physiology and disease.
Takahashi JS, Hong HK, Ko CH, McDearmon EL. Nat Rev Genet. 2008 Oct;9(10):764-75.

DNA vaccines: ready for prime time?Kutzler MA, Weiner DB. Nat Rev Genet. 2008 Oct;9(10):776-88.

Disability and genetics in the era of genomic medicine.Scully JL. Nat Rev Genet. 2008 Oct;9(10):797-802.

Communicating about screening Entwistle VA et al. BMJ 2008;337:a1591

Phenotype, diagnosis, and treatment of Gaucher's disease

Grabowski GA, Lancet 2008; 372:1263-1271

Clinical practice. Autosomal dominant polycystic kidney disease.
Grantham JJ, N Engl J Med. 2008 Oct 2;359(14):1477-85

Population genetic screening for hereditary haemochromatosis: are we a step closer?
Allen KJ. Med J Aust. 2008 Sep 15;189(6):300-1.

Kidney disease and African ancestry.Pollak MR. Nat Genet. 2008 Oct;40(10):1145-6

Cell therapies for muscular dystrophy.
Blau HM. N Engl J Med. 2008 Sep 25;359(13):1403-5.

Patient confidentiality and consent to publication.
Smith J. BMJ. 2008 Sep 10;337:a1572. doi: 10.1136/bmj.a1572.

Casting a wider net for diabetes susceptibility genes.
McCarthy MI. Nat Genet. 2008 Sep;40(9):1039-40.

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram L, Tanzi RE. Nat Rev Neurosci. 2008 Oct;9(10):768-78.

Life-cycle of translational research on medical interventions
Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP. Science. 2008 Sep 5;321(5894):1298-9.

Pharmacogenetics in drug discovery and development: a translational perspective
Roses AD. Nat Rev Drug Discov. 2008 Oct;7(10):807-17.

Proteomics ponders prime time

Proteomics. Will biomarkers take off at last?Service RF. Science. 2008 Sep 26;321(5897):1760.

Technology in global health: the need for essential diagnostics

Houpt ER, Guerrant RL. Lancet. 2008 Sep 13;372(9642):873-4.

Do we need "synthetic bioethics"?
Parens E, Johnston J, Moses J. Science. 2008 Sep 12;321(5895):1449.

Identifying modifier genes of monogenic disease: strategies and difficulties
Génin E, Feingold J, Clerget-Darpoux F. Hum Genet. 2008 Sep 11.

New handles on genomic structural variation.Nat Genet. 2008 Oct;40(10):1143

Emerging themes and new challenges in defining the role of structural variation in human disease.Sharp AJ. Hum Mutat. 2008 Oct 3

Big data: How do your data grow?
Scientific publishing standards

Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new.
Porteous D. Curr Opin Genet Dev. 2008 Aug 29. [Epub ahead of print]

More from us